文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

HIV-1与新型冠状病毒:两种大流行病原体的进化模式

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

作者信息

Fischer Will, Giorgi Elena E, Chakraborty Srirupa, Nguyen Kien, Bhattacharya Tanmoy, Theiler James, Goloboff Pablo A, Yoon Hyejin, Abfalterer Werner, Foley Brian T, Tegally Houriiyah, San James Emmanuel, de Oliveira Tulio, Gnanakaran Sandrasegaram, Korber Bette

机构信息

T-6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA; New Mexico Consortium, Los Alamos, New Mexico, 87545, USA.

T-6: Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA.

出版信息

Cell Host Microbe. 2021 Jul 14;29(7):1093-1110. doi: 10.1016/j.chom.2021.05.012. Epub 2021 Jun 3.


DOI:10.1016/j.chom.2021.05.012
PMID:34242582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8173590/
Abstract

Humanity is currently facing the challenge of two devastating pandemics caused by two very different RNA viruses: HIV-1, which has been with us for decades, and SARS-CoV-2, which has swept the world in the course of a single year. The same evolutionary strategies that drive HIV-1 evolution are at play in SARS-CoV-2. Single nucleotide mutations, multi-base insertions and deletions, recombination, and variation in surface glycans all generate the variability that, guided by natural selection, enables both HIV-1's extraordinary diversity and SARS-CoV-2's slower pace of mutation accumulation. Even though SARS-CoV-2 diversity is more limited, recently emergent SARS-CoV-2 variants carry Spike mutations that have important phenotypic consequences in terms of both antibody resistance and enhanced infectivity. We review and compare how these mutational patterns manifest in these two distinct viruses to provide the variability that fuels their evolution by natural selection.

摘要

人类目前正面临着由两种截然不同的RNA病毒引发的两场毁灭性大流行的挑战:一种是与我们共存数十年的HIV-1,另一种是在短短一年内席卷全球的SARS-CoV-2。驱动HIV-1进化的相同进化策略也在SARS-CoV-2中发挥作用。单核苷酸突变、多碱基插入和缺失、重组以及表面聚糖的变异都会产生变异性,在自然选择的引导下,这种变异性使HIV-1具有非凡的多样性,也使SARS-CoV-2的突变积累速度较慢。尽管SARS-CoV-2的多样性较为有限,但最近出现的SARS-CoV-2变体携带的刺突蛋白突变在抗体抗性和增强传染性方面都具有重要的表型后果。我们回顾并比较了这些突变模式在这两种不同病毒中的表现方式,以提供推动它们通过自然选择进化的变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/2d5525a5b98a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/42ea4d27639b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/5c58a2c25f4a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/c767b23d31d5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/2d928ccfde40/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/2d5525a5b98a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/42ea4d27639b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/5c58a2c25f4a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/c767b23d31d5/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/2d928ccfde40/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37a6/8173590/2d5525a5b98a/gr5_lrg.jpg

相似文献

[1]
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Cell Host Microbe. 2021-7-14

[2]
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.

Genes (Basel). 2020-12-24

[3]
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Elife. 2020-10-28

[4]
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.

mBio. 2021-12-21

[5]
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.

Int J Mol Sci. 2021-3-17

[6]
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics.

Viruses. 2022-7-22

[7]
Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections.

Front Immunol. 2021

[8]
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape.

Science. 2021-3-12

[9]
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.

Front Immunol. 2022

[10]
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.

Viruses. 2021-2-4

引用本文的文献

[1]
Allosteric Control and Glycan Shielding Adaptations in the SARS-CoV-2 Spike from Early to Peak Virulence.

bioRxiv. 2025-3-12

[2]
Changes in the dynamic characteristics of G-protein can alter the immune-protection efficacy of rabies virus vaccine.

J Virol. 2025-3-18

[3]
HIV-1 adapts to HLA class II-associated selection pressure exerted by CD4 and CD8 T cells.

Sci Adv. 2025-2-14

[4]
Selective Diversity in RNA Viruses: Do They Know How to Evolve? A Hypothesis.

Bioessays. 2025-4

[5]
Metabolomic Profiling Reveals Potential Biomarkers and Prominent Features in HIV/AIDS Patients Co-Infected with SARS-CoV-2.

Microorganisms. 2025-1-13

[6]
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity.

Commun Biol. 2025-1-15

[7]
T Cell Resistance: On the Mechanisms of T Cell Non-activation.

Immune Netw. 2024-12-19

[8]
Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques.

Front Immunol. 2024

[9]
Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine.

Top Antivir Med. 2024-4-18

[10]
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection - Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance.

Med Sci Monit. 2024-4-1

本文引用的文献

[1]
TNT version 1.5, including a full implementation of phylogenetic morphometrics.

Cladistics. 2016-6

[2]
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.

Open Forum Infect Dis. 2021-3-30

[3]
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.

mBio. 2021-8-31

[4]
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.

Science. 2021-8-6

[5]
Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.

Nat Microbiol. 2021-8

[6]
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.

Cell. 2021-6-24

[7]
Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.

Genetics. 2021-7-14

[8]
The SARS-CoV-2 Spike variant D614G favors an open conformational state.

Sci Adv. 2021-4

[9]
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.

Cell Host Microbe. 2021-5-12

[10]
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.

Cell. 2021-4-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索